Rapid toxicology test BZO

drug detectionfor abused drugsfor benzodiazepines

Overview
Xenta Benzodiazepines (BZO) rapid test kit is an in vitro diagnostic product based on a gold immunochromatographic assay for the rapid detection of benzodiazepines in human urine.

Product Details
Product Name: Benzodiazepines (BZO) Rapid Test Kit
Catalog No.: GD-QCY-0008
Certification: FDA
Test Tools: Drug screen cup / drug screen dipcard
Analyte: Benzodiazepines
Complexity: Moderate
Sample Types: Urine
Cut-off Level: 300 ng/mL
Validation Methods: GC-MS
Test Time: 5 min
Test Temperature: 15-30°C
Storage: Store at 2-30°C.
Application: This kit is intended for in vitro diagnosis of benzodiazepines in human urine.

Operations

• Donor collects urine specimen in a urine cup.
• Open the sealed pouch at the notch, remove the test device and place it on a level surface.
• Hold the sample dropper vertically and add exactly three drops of urine into the sample well.
• Read the result at 5 minutes. Do not interpret results after 10 minutes.

Packaging / Quantities
10 tests per kit.

Features / Technical specifications

• Assay type: Gold immunochromatographic assay (colloidal gold)
• Intended use: In vitro diagnosis of benzodiazepines in human urine
• Analyte detected: Benzodiazepines
• Sample type: Urine
• Cut-off concentration: 300 ng/mL
• Validation reference method: GC-MS
• Result time: 5 minutes
• Operating temperature range: 15-30°C
• Storage conditions: 2-30°C
• Test formats supported: Drug screen cup, drug screen dipcard
• Complexity: Moderate